Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anjali Pandey

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|March 31, 2011
Thienopyridines, but not elinogrel, result in off-target effects at the vessel wall that contribute to bleedingPatrick André, Francis DeGuzman, Helena Haberstock-Debic, et al.
Bioorganic & Medicinal Chemistry Letters|July 15, 2011
Psilostachyin, acetylated pseudoguaianolides and their analogues: preparation and evaluation of their anti-inflammatory potentialRenu Chib, Bhahwal Ali Shah, Naveen Anand, et al.
Journal of Clinical Pharmacology|July 14, 2016
PRT062607 Achieves Complete Inhibition of the Spleen Tyrosine Kinase at Tolerated Exposures Following Oral Dosing in Healthy VolunteersGreg Coffey, Aradhana Rani, Andreas Betz, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Identification of 4-piperazin-1-yl-quinazoline template based aryl and benzyl thioureas as potent, selective, and orally bioavailable inhibitors of platelet-derived growth factor (PDGF) receptorJulie A Heath, Mukund M Mehrotra, Shannon Chi, et al.
Blood|November 20, 2010
PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse modelMichael P Reilly, Uma Sinha, Pierrette André, et al.
Organic & Biomolecular Chemistry|July 31, 2009
Saponins as novel TNF-alpha inhibitors: isolation of saponins and a nor-pseudoguaianolide from Parthenium hysterophorusBhahwal Ali Shah, Renu Chib, Pankaj Gupta, et al.
Journal of Medicinal Chemistry|August 9, 2002
Identification of orally active, potent, and selective 4-piperazinylquinazolines as antagonists of the platelet-derived growth factor receptor tyrosine kinase familyAnjali Pandey, Deborah L Volkots, Joseph M Seroogy, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2002
Spirocyclic nonpeptide glycoprotein IIb-IIIa antagonists. Part 3: synthesis and SAR of potent and specific 2,8-diazaspiro[4.5]decanesMukund M Mehrotra, Julie A Heath, Jack W Rose, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2011
Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritisGreg Coffey, Francis DeGuzman, Mayuko Inagaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 19, 2018
Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell MalignanciesGreg P Coffey, Jiajia Feng, Andreas Betz, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|March 31, 2011
Thienopyridines, but not elinogrel, result in off-target effects at the vessel wall that contribute to bleedingPatrick André, Francis DeGuzman, Helena Haberstock-Debic, et al.
Bioorganic & Medicinal Chemistry Letters|July 15, 2011
Psilostachyin, acetylated pseudoguaianolides and their analogues: preparation and evaluation of their anti-inflammatory potentialRenu Chib, Bhahwal Ali Shah, Naveen Anand, et al.
Journal of Clinical Pharmacology|July 14, 2016
PRT062607 Achieves Complete Inhibition of the Spleen Tyrosine Kinase at Tolerated Exposures Following Oral Dosing in Healthy VolunteersGreg Coffey, Aradhana Rani, Andreas Betz, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Identification of 4-piperazin-1-yl-quinazoline template based aryl and benzyl thioureas as potent, selective, and orally bioavailable inhibitors of platelet-derived growth factor (PDGF) receptorJulie A Heath, Mukund M Mehrotra, Shannon Chi, et al.
Blood|November 20, 2010
PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse modelMichael P Reilly, Uma Sinha, Pierrette André, et al.
Organic & Biomolecular Chemistry|July 31, 2009
Saponins as novel TNF-alpha inhibitors: isolation of saponins and a nor-pseudoguaianolide from Parthenium hysterophorusBhahwal Ali Shah, Renu Chib, Pankaj Gupta, et al.
Journal of Medicinal Chemistry|August 9, 2002
Identification of orally active, potent, and selective 4-piperazinylquinazolines as antagonists of the platelet-derived growth factor receptor tyrosine kinase familyAnjali Pandey, Deborah L Volkots, Joseph M Seroogy, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2002
Spirocyclic nonpeptide glycoprotein IIb-IIIa antagonists. Part 3: synthesis and SAR of potent and specific 2,8-diazaspiro[4.5]decanesMukund M Mehrotra, Julie A Heath, Jack W Rose, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2011
Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritisGreg Coffey, Francis DeGuzman, Mayuko Inagaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 19, 2018
Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell MalignanciesGreg P Coffey, Jiajia Feng, Andreas Betz, et al.
Pageof 8